Xiao Ding

机构：Kunming Institute of Botany, Chinese Academy of Medical Sciences & Peking Union Medical College, Insilicos (United States), INSEAD, Pudong New Area People's Hospital · ORCID：0000-0003-3482-1870

发表论文 53 篇 · 总被引 1021 次 · h-index 15

代表论文

• A novel, covalent broad-spectrum inhibitor targeting human coronavirus Mpro (2025 · Nature Communications · 被引 35)
• Discovery of Pyridine-2-Carboxamides Derivatives as Potent and Selective HPK1 Inhibitors for the Treatment of Cancer (2024 · Journal of Medicinal Chemistry · 被引 27)
• Discovery of a bifunctional PKMYT1-targeting PROTAC empowered by AI-generation (2025 · Nature Communications · 被引 18)
• Discovery of Pyrrolopyrazine Carboxamide Derivatives as Potent and Selective FGFR2/3 Inhibitors that Overcome Mutant Resistance (2025 · Journal of Medicinal Chemistry · 被引 15)
• Discovery of pyrrolopyrimidinone derivatives as potent PKMYT1 inhibitors for the treatment of cancer (2024 · European Journal of Medicinal Chemistry · 被引 15)
• Discovery of a Novel and Potent Cyclin-Dependent Kinase 8/19 (CDK8/19) Inhibitor for the Treatment of Cancer (2024 · Journal of Medicinal Chemistry · 被引 14)